SCHEINER, BERNHARD
 Distribuzione geografica
Continente #
AS - Asia 391
NA - Nord America 337
EU - Europa 226
SA - Sud America 71
AF - Africa 47
Totale 1.072
Nazione #
US - Stati Uniti d'America 310
SG - Singapore 145
HK - Hong Kong 105
BR - Brasile 55
RU - Federazione Russa 52
CN - Cina 44
BJ - Benin 42
IT - Italia 28
DE - Germania 26
AT - Austria 25
KR - Corea 24
GB - Regno Unito 23
VN - Vietnam 23
CA - Canada 16
FR - Francia 15
IN - India 15
AR - Argentina 12
BD - Bangladesh 9
JP - Giappone 9
PL - Polonia 8
SE - Svezia 8
UA - Ucraina 8
MX - Messico 7
NL - Olanda 7
FI - Finlandia 6
IE - Irlanda 6
CH - Svizzera 4
ES - Italia 4
LT - Lituania 4
IQ - Iraq 3
TR - Turchia 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
EC - Ecuador 2
PH - Filippine 2
ZA - Sudafrica 2
BE - Belgio 1
BG - Bulgaria 1
CO - Colombia 1
CR - Costa Rica 1
EG - Egitto 1
GE - Georgia 1
IL - Israele 1
KH - Cambogia 1
KZ - Kazakistan 1
MA - Marocco 1
NP - Nepal 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 1.072
Città #
Hong Kong 101
Singapore 73
Ashburn 54
Cotonou 42
Los Angeles 34
Seoul 24
Beijing 23
Buffalo 16
Vienna 14
Moscow 13
São Paulo 13
New York 12
Brooklyn 9
Denver 9
Nuremberg 9
Tokyo 9
Stockholm 8
Warsaw 8
Dublin 7
Ho Chi Minh City 7
Assago 6
Chicago 6
Falkenstein 6
Frankfurt am Main 6
Orem 6
Boston 5
Chennai 5
Helsinki 5
London 5
Phoenix 5
Santa Clara 5
Toronto 5
Dhaka 4
Manchester 4
Poplar 4
Zurich 4
Amsterdam 3
Baie-D'Urfé 3
Boardman 3
Dallas 3
Elk Grove Village 3
Hanoi 3
Honolulu 3
Houston 3
Montreal 3
Mumbai 3
Roubaix 3
Turin 3
Uberlândia 3
Ankara 2
Atlanta 2
Baghdad 2
Bexley 2
Calgary 2
Deiva Marina 2
Johannesburg 2
Manila 2
Mexico City 2
New Delhi 2
Paris 2
Querétaro 2
Raleigh 2
Ryazan 2
Seattle 2
Secaucus 2
Sorocaba 2
Taubaté 2
Agrolândia 1
Aktobe 1
América 1
Apodaca 1
Apollo 1
Apucarana 1
Aracaju 1
Baytown 1
Belford Roxo 1
Bismarck 1
Boca Raton 1
Bologna 1
Botucatu 1
Boulogne Sur Mer 1
Brussels 1
Buenos Aires 1
Cabreúva 1
Cairo 1
Camden 1
Campinas 1
Cao Lanh 1
Caraguatatuba 1
Centenario 1
Chaguanas 1
Chittagong 1
Cleveland 1
Concord 1
Coronel Suárez 1
Cradley Heath 1
Curitiba 1
Córdoba 1
Da Nang 1
Dakhla 1
Totale 674
Nome #
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 67
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma 61
Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice 53
Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors 50
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab 48
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma 47
Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma 46
PETAL protocol: A phase Ib study of pembrolizumab after transarterial chemoembolization in hepatocellular carcinoma 46
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study 46
Immunotherapy vs Best Supportive Care for Patients with Hepatocellular Cancer with Child-Pugh B Dysfunction 44
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours 44
Immune Checkpoint Inhibitors for Child-Pugh Class B Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis 41
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study 39
Outcome and management of patients with hepatocellular carcinoma who achieved complete response to immunotherapy-based systemic therapy 39
A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma 39
Disturbances in sodium and chloride homeostasis predict outcome in stable and critically ill patients with cirrhosis 38
Refining patient selection for next-generation immunotherapeutic early-phase clinical trials with a novel and externally validated prognostic nomogram 38
Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study 38
Association between antibiotics and adverse oncological outcomes in patients receiving targeted or immune-based therapy for hepatocellular carcinoma 38
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study 37
The systemic inflammatory response identifies patients with adverse clinical outcome from immunotherapy in hepatocellular carcinoma 36
Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213) 36
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study 36
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma 35
Tumor-infiltrating Neutrophils: Gatekeepers in Liver Cancer Immune Control 24
Transversal psoas muscle thickness measurement is associated with response and survival in patients with HCC undergoing immunotherapy 21
The Hammersmith Score Optimises Patient Selection and Predicts for Overall Survival in Early-Phase Cancer Trial Participants Independent of Tumour Burden 17
Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidence 1
Lenvatinib vs. sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: The LEVIATHAN study 1
Totale 1.106
Categoria #
all - tutte 6.869
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.869


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202459 16 1 6 1 8 0 8 4 0 1 0 14
2024/2025468 8 0 30 2 6 35 57 60 102 58 22 88
2025/2026579 64 43 79 165 217 11 0 0 0 0 0 0
Totale 1.106